Assessment of the relative systemic potency of inhaled fluticasone and budesonide
Open accessThe DOI matches its Crossref record.
Abstract
Studies using dry powder devices have suggested that fluticasone propionate (FP) has a greater systemic effect than budesonide (BUD). The aim of the present study was to investigate and compare the relative systemic potency of FP and BUD from their respective pressurized metered-dose inhalers (pMDIs). A placebo-controlled, open, randomized, cross-over study was conducted in 21 healthy male volunteers. Placebo, BUD (200, 400 and 1,000 micrograms b.i.d.) and FP (200, 375 and 1,000 micrograms b.i.d.) were inhaled for 4 days, with a wash-out period of at least 3 days between treatments. Blood samples for cortisol analysis were drawn during the last 24 h of each treatment period. Cortisol levels, measured as 24 h pooled plasma cortisol, were statistically significantly lower (p = 0.0001) for all dose levels during FP pMDI treatment (21, 39 and 84% suppression from placebo) than during BUD pMDI treatment (1, 3 and 27% suppression from placebo). The relative systemic potency FP:BUD was 3.7:1 (95% confidence interval (95% CI) 2.9-4.8)). The relative systemic potency based on the single 08:00 h samples was 5.2:1 (95% CI 3.0-9.3). In conclusion, in healthy male volunteers using pressurized metered-dose inhalers, fluticasone propionate was shown to have a stronger systemic effect than budesonide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
National Asthma Education and Prevention Program
VanGraafeiland, B. (2002) · The Nurse Practitioner · doi:10.1097/00006205-200206001-00003 · Cited by 1,091
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
“on the steep part of their respective dose-response curves using a sufficiently sensitive end point.(28-31) It is not valid”
BackgroundMethodEfficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
Pedersen, S., & O'Byrne, P. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb05047.x · Cited by 352
Systemic Effect Comparisons of Six Inhaled Corticosteroid Preparations
Martin, R. J., Szefler, S. J., Chinchilli, V. M., Kraft, M., Dolovich, M., Boushey, H. A., Cherniack, R. M., Craig, T. J., Drazen, J. M., Fagan, J. K., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105013 · Cited by 256
Metadata
- Authors
- Boorsma, M., Andersson, N., Larsson, P., & Ullman, A.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 1996-06-01
- Volume
- 9
- Issue
- 7
- Pages
- 1427-1432
- ISSN
- 0903-1936 (ISSN-L)
- 0000-0000
- OpenAlex
- W2153657940
- Cited by
- 103
- References
- 0
- FWCI
- 18.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of the relative systemic potency of inhaled fluticasone and budesonide. https://app.cochat.ai/papers/10.1183/09031936.96.09071427
- The paper
- Boorsma, M., Andersson, N., Larsson, P., & Ullman, A. (1996). Assessment of the relative systemic potency of inhaled fluticasone and budesonide. European Respiratory Journal. https://doi.org/10.1183/09031936.96.09071427
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.